E-LIB Suche - Ergebnisse für: Fiolet, Aernoud T.L.

1

Cost-effectiveness of low-dose colchicine in patients with ..:

Fiolet, Aernoud T L ; Keusters, Willem ; Blokzijl, Johan...
European Heart Journal - Quality of Care and Clinical Outcomes. , 2024

Link: https://doi.org/10.1093/..

2

Colchicine and diabetes in patients with chronic coronary a..:

Mohammadnia, Niekbachsh ; Los, Jan ; Opstal, Tjerk S. J....
Frontiers in Cardiovascular Medicine. 10 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

3

Individual lifetime benefit from low-dose colchicine in pat..:

Burger, Pascal M ; Dorresteijn, Jannick A N ; Fiolet, Aernoud T L...
European Journal of Preventive Cardiology. 30 (2023) 18 - p. 1950-1962 , 2023

Link: https://doi.org/10.1093/..

4

Drivers of mortality in patients with chronic coronary dise..:

Opstal, Tjerk S.J. ; Nidorf, Stefan M. ; Fiolet, Aernoud T.L....
International Journal of Cardiology. 372 (2023) - p. 1-5 , 2023

Link: https://doi.org/10.1016/..

5

The Effect of Years-Long Exposure to Low-Dose Colchicine on..:

van Broekhoven, Amber ; Mohammadnia, Niekbachsh ; Silvis, Max J. M....
Clinical Drug Investigation. 42 (2022) 11 - p. 977-985 , 2022

Link: https://doi.org/10.1007/..

6

Association of genetic variations in ACE2, TIRAP and factor..:

Traets, Marissa J. M. ; Nijhuis, Roel H. T. ; Morré, Servaas A....
PLOS ONE. 17 (2022) 1 - p. e0260897 , 2022

Link: https://doi.org/10.1371/..

7

Colchicine reduces extracellular vesicle NLRP3 inflammasome..:

Silvis, Max J.M. ; Fiolet, Aernoud T.L. ; Opstal, Tjerk S.J....
Atherosclerosis. 334 (2021) - p. 93-100 , 2021

Link: https://doi.org/10.1016/..

8

Experimental parameters and infarct size in closed chest pi..:

Silvis, Max J. M. ; van Hout, Gerardus P. J. ; Fiolet, Aernoud T. L....
BMC Cardiovascular Disorders. 21 (2021) 1 - p. , 2021

Link: https://doi.org/10.1186/..

9

Text-mining in electronic healthcare records can be used as..:

van Dijk, Wouter B. ; Fiolet, Aernoud T.L. ; Schuit, Ewoud...
Journal of Clinical Epidemiology. 132 (2021) - p. 97-105 , 2021

Link: https://doi.org/10.1016/..

10

Efficacy and safety of low-dose colchicine in patients with..:

Fiolet, Aernoud T L ; Opstal, Tjerk S J ; Mosterd, Arend...
European Heart Journal. 42 (2021) 28 - p. 2765-2775 , 2021

Link: https://doi.org/10.1093/..

11

Letter to the editor: Colchicine and risk ofnon-cardiovascu..:

Fiolet, Aernoud T L ; Opstal, Tjerk S J ; Mosterd, Arend...
European Heart Journal - Cardiovascular Pharmacotherapy. 7 (2021) 4 - p. e71-e71 , 2021

Link: https://doi.org/10.1093/..

12

Colchicine in coronary disease: another renaissance of an a..:

Fiolet, Aernoud T L ; Thompson, Peter L ; Mosterd, Arend
Cardiovascular Research. 117 (2020) 1 - p. e4-e6 , 2020

Link: https://doi.org/10.1093/..

13

Short-term effect of low-dose colchicine on inflammatory bi..:

Fiolet, Aernoud T. L. ; Silvis, Max J. M. ; Opstal, Tjerk S. J....
PLOS ONE. 15 (2020) 8 - p. e0237665 , 2020

Link: https://doi.org/10.1371/..

14

Immunomodulation of the NLRP3 Inflammasome in Atheroscleros..:

Silvis, Max J. M. ; Demkes, Evelyne J. ; Fiolet, Aernoud T. L....
Journal of Cardiovascular Translational Research. 14 (2020) 1 - p. 23-34 , 2020

Link: https://doi.org/10.1007/..

15

Colchicine for secondary prevention in coronary disease:

Fiolet, Aernoud T L ; Nidorf, S Mark ; Cornel, Jan H.
European Heart Journal. 42 (2020) 11 - p. 1060-1061 , 2020

Link: https://doi.org/10.1093/..